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Abstract
Menthol is a common compound in pharmaceutical and commercial products and a popular additive to cigarettes. The
molecular targets of menthol remain poorly defined. In this study we show an effect of menthol on the a7 subunit of the
nicotinic acetylcholine (nACh) receptor function. Using a two-electrode voltage-clamp technique, menthol was found to
reversibly inhibit a7-nACh receptors heterologously expressed in Xenopus oocytes. Inhibition by menthol was not
dependent on the membrane potential and did not involve endogenous Ca2+-dependent Cl2 channels, since menthol
inhibition remained unchanged by intracellular injection of the Ca2+ chelator BAPTA and perfusion with Ca2+-free bathing
solution containing Ba2+. Furthermore, increasing ACh concentrations did not reverse menthol inhibition and the specific
binding of [125I] a-bungarotoxin was not attenuated by menthol. Studies of a7- nACh receptors endogenously expressed in
neural cells demonstrate that menthol attenuates a7 mediated Ca
2+ transients in the cell body and neurite. In conclusion,
our results suggest that menthol inhibits a7-nACh receptors in a noncompetitive manner.
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Introduction
Menthol is a monocyclic terpene alcohol used widely as a
flavoring and cooling additive in a number of pharmaceutical and
commercial products [1,2]. It is used by the tobacco industry to
mask the harshness, increase the ease of smoking and provide a
cooling sensation that appeals to many smokers [3]. In fact,
menthol has been reported to be present in varying concentrations
in 90 percent of tobacco products [4]. Menthol as an additive has
come under close scrutiny following recent FDA reports [5]
suggesting that it may facilitate smoking behavior and promote an
adverse effect of smoking on health. Evidence also suggests that
smoking of mentholated cigarettes is more prevalent in racial/
ethnic minority populations and that smokers of mentholated
cigarettes tend to smoke fewer cigarettes per day than regular
cigarette smokers (for reviews, [6,7,4]). An association between
smoking menthol cigarettes and a greater difficulty in quitting
smoking is also greater in racial/ethnic minority populations as
well as young smokers [4].
Nicotine, an alkaloid found in the tobacco, is considered to
mediate most of the pharmacological and addictive properties of
tobacco via its direct actions on nicotinic acetylcholine (nACh)
receptors (for a review, [8]). Interaction between menthol and
nACh receptors has been examined previously both in vivo and in
vitro [9,10,11,12]. For example, irritation and sensory perception
induced by nicotine [9] and cigarette smoke inhalation [11] are
significantly reduced by menthol. In addition to sensory responses,
nicotine-induced decreases in body temperature, due to cutaneous
vasodilation, are diminished significantly after both chronic and
acute menthol administrations [10]. Menthol’s ability to trigger
the cold-sensitive transient receptor potential melastatin (TRPM)
receptor is thought to be a mechanism for the cooling sensation it
provokes when inhaled, eaten, or applied to the skin.
In the central nervous system, the nACh receptor can be
broadly divided into two classes, heteromeric b-subunit containing
receptors and homomeric a7-type receptors [13,14]. Recently
menthol has been shown to regulate the function [12] and
expression [15] of a4b2-nACh receptors in the brain. To date
however, little is known about menthol actions on other nACh
receptors. In this study, we have tested the hypothesis that menthol
modulates the function of the calcium conducting a7-nACh
receptor. We have examined the effects of menthol on the function
of human a7-nACh receptors expressed in Xenopus oocytes and rat
a7-nACh receptors endogenously expressed in cultured neural
cells. Our findings reveal a novel role for menthol in the
modulation of a7-nACh receptors and suggest that this compound
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may contribute to cholinergic transmission as well as nicotine
addiction.
Materials and Methods
Recordings from oocytes
Mature female Xenopus laevis frogs were purchased from
Xenopus Express (Haute-Loire, France), housed in dechlorinated
tap water at 19–21uC with a 12/12-hour light/dark cycle, and fed
food pellets supplied by Xenopus Express. The procedures
followed in this study were in accordance with the Guide for the
Care and Use of Laboratory Animals (8th edition) of the National
Institutes of Health (Bethesda, MD) and approved by the
Institutional Animal Care and Use Committee at the UAEU.
Clusters of oocytes were removed surgically under benzocaine
(Sigma, St. Louis, MO) local anesthesia (0.15% w/V), and
individual oocytes were dissected manually in a solution contain-
ing (in mM): NaCl, 88; KCl, 1; NaHCO3, 2.4; MgSO4, 0.8;
HEPES, 10 (pH 7.5). Dissected oocytes were then stored 2–7 days
in modified Barth’s solution (MBS) containing (in mM): NaCl, 88;
KCl, 1; NaHCO3, 2.4; CaCl2, 2; MgSO4, 0.8; HEPES, 10
(pH 7.5), supplemented with sodium pyruvate, 2 mM, penicillin
10,000 IU/L, streptomycin, 10 mg/L, gentamicin, 50 mg/L, and
theophylline, 0.5 mM. Briefly, oocytes were placed in a 0.2 ml
recording chamber and superfused at a rate of 2–3 ml/min. The
bathing solution consisted of (in mM): NaCl, 95; KCl, 2; CaCl2, 2;
and HEPES 5 (pH 7.5). The cells were impaled with two glass
microelectrodes filled with a 3 M KCl (1–5 MV). The oocytes
were routinely voltage clamped at a holding potential of 270 mV
using a GeneClamp-500 amplifier (Axon Instruments Inc.,
Burlingame, CA). During experiments on the current-voltage
relationship of ACh-responses, membrane potentials from 2100
to 220 mV were held for 30 sec to 1 min and then returned to
270 mV.
Drugs were applied by gravity flow via a micropipette
positioned about 2 mm from the surface of the oocyte. Some of
the compounds were applied externally by addition to the
superfusate. All chemicals used in preparing the solutions were
from Sigma-Aldrich (St. Louis, MO). Racemic, (2) and (+)-
menthol, acetylcholine, and a-bungarotoxin were obtained from
Sigma (St. Louis, MO). Procedures for the injections of BAPTA
(50–100 nl, 100 mM) were performed as described previously
[16]. BAPTA was prepared in Cs4-BAPTA and injections were
performed 1 hr prior to recordings using an oil-driven ultra
microsyringe pump (Micro4, WPI, Inc. Sarasota, FL). Stock
solutions of menthol used in this study were prepared in ethanol at
a concentration of 10 mM.
cDNA plasmids for human a7-nACh receptor expression were
kindly provided by Dr. J. Lindstrom (University of Pennsylvania,
PA). Capped cRNA transcripts were synthesized in vitro using a
mMESSAGE mMACHINE kit from Ambion (Austin, TX) and
analyzed on a 1.2% formaldehyde agarose gel to check the size
and quality of the transcripts.
Radioligand binding studies
Oocytes were injected with 10 ng human a7-nicotinic acetyl-
choline receptor cRNA, and the functional expression of the
receptors was tested by electrophysiology after 2 days. Isolation of
oocyte membranes was carried using a published method [17].
Briefly, oocytes (200–300 oocytes per assay) were suspended
(approximately 20 ml/oocyte) in a homogenization buffer contain-
ing HEPES 10 mM, EDTA 1 mM, 0.02% NaN3, 50 mg/mL
bacitracin, and 0.1 mM PMSF (pH 7.4) at 4uC on ice and
homogenized using a motorized Teflon homogenizer (six strokes,
15 sec each at high speed). The homogenate was centrifuged for
10 min at 8006 g. The supernatant was collected and the pellet
was suspended in homogenization buffer and centrifuged at 8006
g for 10 min. Supernatants were combined and centrifuged for
1 hr at 360006 g. The membrane pellet was suspended in
homogenization buffer and used in the binding studies.
Binding assays were performed in 500 mL of binding buffer
(in mM; NaCl, 140; KCl, 2.5; CaCl2, 2.5; MgCl2, 1; HEPES 20;
pH 7.4) containing 50 mL of oocyte preparation and 0.1–5 nM
[125I] a-bungarotoxin (2200 Ci/mmol; Perkin-Elmer, Inc.
Waltham, MA). Nonspecific binding was determined using
10 mM a-bungarotoxin. Oocyte membranes were incubated
with [125I] a-bungarotoxin in the absence and presence of
drugs, for 1 hr at room temperature (22–24uC). The radioligand
was separated by rapid filtration onto GF/C filters presoaked in
0.2% polyethyleneimine. Filters were then washed with two
5 ml washes of ice-cold binding buffer, and the radioactivity was
determined by counting samples in a Beckman Gamma-300 c-
counter.
[125I] a-bungarotoxin binding in intact oocytes
2–3 days after injection, [125I] a-bungarotoxin binding assays
were performed subsequent to the voltage-clamp measurement on
the same intact oocyte. A cellular current response (to 100 mM
ACh) of more than 3000 nA was used as an inclusion criteria in
the binding assay. Notably, most oocytes had maximum current
amplitude of 4000 to 6000 nA. Binding assays in single intact
oocytes were carried out by modification to an existing method
[18]. Briefly, oocytes were incubated in 20 nM [125I] a-bungaro-
toxin, 5 mg/mL BSA, MBS at room temperature for 2 hr. Non-
injected oocytes were incubated under the same conditions to
measure non-specific binding. Excess toxin was removed by
washing each oocyte with 25 mL of MBS. Radioactivity was
measured using a Beckman Gamma-300 c-counter. Counts per
minute (cpm) values were calculated from the mean of 4 separate
experiments. In each experiment, 5–6 oocytes were used per
group.
Cell Culture and Immunocytochemistry
Pheocromocytoma line 12 (PC12) cells were grown on a rat
collagen (50 mg/mL, Gibco) matrix using dMEM containing 10%
horse serum, 5% fetal bovine serum (FBS), and 1% penicillin-
streptomycin (Pen-strep) antibiotic as previously described [19].
Cells were differentiated with the addition of 10 nM 2.5S nerve
growth factor (NGF) for 2 days prior to transfection and imaging
(Prince Laboratories). Cells were transfected with a pCMV-
GCaMP5G plasmid (Addgene) using Lipofectamine 2000 (Life
Sciences). An empty pEGFP-N1 plasmid was used as a vector
control.
Cell fixation and immunocytochemistry was performed on
PC12 cells as described [20]. In brief cells were fixed with 0.3%
glutaraldehyde and permeabilized with 0.05% Triton X-100. Cells
were stained with a fluorescently labeled AlexaFluor 647 a-
bungarotoxin (fBgtx) (Life Sciences) and a rhodamine phalloidin
antibody (Cell Signaling). Stained cells were visualized using a
Nikon Eclipse 80i confocal microscope fitted with a Nikon C1
CCD camera. Images were captured using AxioVision and EZ-C1
software.
Calcium Imaging
Calcium imaging was performed using the genetically encoded
calcium sensor protein GCaMP5G (Addgene) (Ackerboom et al,
2012). This method was preformed essentially as described [21]
with some minor modifications. Briefly, PC12 cells cultured on
Effects of Menthol on a7-nACh Receptors
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8 mm coverslips were placed into a recording chamber and
perfused with a recording buffer (in mm; NaCl, 110; KCl, 5.4;
CaCl2, 1.8; MgCl2, 0.8; D-glucose, 10; HEPES, 10 at pH 7.4
(adjusted with NaOH)). Image exposure time was set to 100 msec
and pixel binning was set to 262. Neutral density filters were used
to reduce photobleaching. Imaging was carried out at room
temperature (22uC) for 30 seconds at an acquisition rate of one
image every 500 msec. Drugs were applied via a perfusion bath
after 10 seconds of baseline recording. Baseline fluorescence
readings were taken before drug exposure in 30 s intervals for
5 min (a total of 10 readings). For images presented here, baseline
readings were shortened to five readings. For menthol and Bgtx
applications, cells were preincubated with HBSS+10 mM HEPES
and menthol or Bgtx for 20 min prior to calcium imaging. Regions
of interest (ROIs) within the neurite and soma were chosen based
on co-detection of GCaMP5 and fBgtx. Images were taken using
Zeiss Observer 7.1 fitted with an AxioCam MRm camera and
images were captured using the AxioVision software. Camera
intensification was set to keep exposure times ,50 ms for
GCaMP5; pixel intensities were ,25% of saturation. GCaMP5
fluorescence was acquired with a 488 nm laser and 535/30
emission filter.
A total of 40 cells per experimental group (n = 40) were used to
obtain the average values. Analysis of the fluorescence was
performed using ImageJ (NIH). A fluorescent signal above two
standard deviations of the mean, from the baseline, was
determined as an inclusion criterion in the analysis in order to
dismiss random fluctuations.
Structural Modeling
Docking of L-menthol (1R,2S,5R) to the -nACh muscle
receptor was performed using the structure of L-menthol (ZINC
ID: 01482164) from the ZINC Vr. 12 Database [22]. A crystal
structure for the muscle nACh receptor was obtained from the
Protein Data Bank [23] under PDB ID 2BG9 [24]. This
receptor was chosen as it is the only complete nACh receptor
available in the PDB and it shares close structural homology
with the a7-nACh receptor [25]. Rigid docking simulations
were performed using AutoDock 4.2 [26] and the Molecular
Graphics Laboratory Tools (MGLTools) Vr. 1.5.4 rev. 30
[27,26]. Ligand and receptor files were prepared using
recommended procedures described in the MGLTools software
documentation (http://mgltools.scripps.edu/documentation).
Two torsion angles were specified as parameters for the ligand,
while the receptor was modeled as a rigid structure. A grid box
area was specified to for AutodDock to bind the ligand on
relevant regions of the receptor’s molecular surface. Specifica-
tion of the grid box area took into account the similar binding
characteristics believed to be shared by propofol and menthol
[28], and the close homology of the gamma-aminobutyric acid
receptor (GABAAR) to nACh muscle receptor [25]. The grid
box was set to include key residue positions evaluated by
Williams and Akabas [29] for testing propofol binding to the
GABAAR-a1 segment. These key residues were mapped onto
the muscle nACh and a7-nACh (UniProt AC: P36544) receptor
sequences through a multiple sequence alignment, using
MUSCLE Vr. 3.8.31 [30]. Once the grid box area was set to
include these residues, docking simulations were performed in
AutodDock through the Lamarkian Genetic Algorithm with
default parameters. In order to obtain convergence, the
‘‘maximum number of evaluations’’ was increased to ‘‘long.’’
Analysis of the generated docked conformations for the ligand
was performed using MGLTools. Image rendering was per-
formed using VMD 1.9 [31].
Data analysis
Average values were calculated as the mean 6 standard error
means (S.E.M.). Throughout this study, n defines the number of
oocytes or number of samples tested in each experiment. Statistical
significance was analyzed using Student’s t test or ANOVA as
indicated. Concentration-response curves were obtained by fitting
the data to the logistic equation,
y~Emax=(1z½x=EC50{n)
where x and y are concentration and response, respectively, Emax
is the maximal response, EC50 is the half-maximal concentration,
and n is the slope factor (apparent Hill coefficient).
Results
Menthol attenuates a7-nACh receptor activity
At the highest concentration used in this study, 1 mM
acetylcholine (ACh) did not cause detectable currents in un-
injected oocytes (n = 7) or in oocytes injected with distilled water
(n = 6) (data not shown). Application of 100 mM ACh for 3 to 4 sec
activated fast inward currents that desensitized rapidly in oocytes
injected with cRNA transcribed from cDNA encoding the a7-
subunit of human nACh receptor. Moreover, ACh-induced
inward currents were abolished completely with 100 nM a-
bungarotoxin (n = 7, data not shown), indicating that the a-
bungarotoxin-sensitive a7-nACh receptor-ion channel mediates
these responses.
The effects of 10 min incubation with menthol (30 mM) on a7-
nACh receptor mediated currents are shown in Fig. 1A. A time-
course plot showing the effect of menthol application on the
amplitudes of ACh-induced currents is presented in Fig. 1B.
Whereas the vehicle solution did not alter ACh-induced currents,
application of menthol (30 mM) caused a significant inhibition of
the current. This inhibition by menthol was partially reversed
during a washout period of 10 to 15 min. In the absence of these
drugs, maximal amplitudes of currents elicited by the application
of 100 mM ACh every 5 min remained unchanged during the
course of the experiments (Fig. 1B, controls).
Some of the biological actions of menthol have been shown to
be stereo-specific (Eccles, 1994). For this reason, we compared the
effects of 100 mM of (2) and (+) stereoisomers, and racemic (6)
menthol on human a7-nACh receptors. Results show that the 2
stereoisomers and the racemic menthol (100 mM) inhibit nACh
receptor currents to a similar extent with no statistical significant
detected between the compounds (Fig. 1C; n = 6–7, F (2,
16) = 0.322; ANOVA, P.0.05). In all subsequent experiments,
unless stated, racemic (6) menthol was employed.
Menthol is often delivered with tobacco products that contain
nicotine. Therefore we tested the effect of menthol on nicotine-
activated currents in oocytes. As shown in Fig. 1D, we did not find
a statistically significant difference in menthol-mediated inhibition
of a7-nACh receptor currents between cells treated with ACh or
nicotine (n = 5–6, F (1, 9) = 0.052; ANOVA, P.0.05). It is
noteworthy that the inhibitory effect of menthol was dependent
on the application mode. Without menthol pre-incubation, a co-
application of menthol (30 mM) and ACh (100 mM) did not alter
the amplitudes of maximal currents (Fig. 2A). However after pre-
incubation, menthol inhibited the maximal responses in a time-
dependent manner. As incubation time was prolonged, the extent
of menthol inhibition was enhanced and reached a maximum level
at 10 to 15 min (Fig. 1B). Close examination of the time course of
menthol actions indicated that the inhibition occurs at fast and
slow phases with the respective time constants of t1/2fast = 23 sec.
Effects of Menthol on a7-nACh Receptors
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and t1/2slow = 5.2 min (Fig. 2A). Since the magnitude of the effect
was time-dependent, menthol was applied for 10 to 15 min to
ensure equilibrium conditions. Menthol inhibited the function of
a7-nACh receptor in a concentration-dependent manner with
respective IC50 and slope values of 32.662.3 mM and 1.7,
respectively (Fig. 2B).
G-protein coupled receptors [32] have been shown to be
involved in cellular and behavioral effects of menthol. Thus, we
tested the effect of menthol in control (distilled-water injected) and
pertussis toxin (PTX) - injected oocytes expressing nACh
receptors. There was no significant difference in menthol
inhibition of ACh responses between controls and PTX-injected
cells (Figure 3A, n = 7–8; F (1, 14) = 0.692, ANOVA, P.0.05 for
the significance of menthol inhibition between controls and PTX
group).
Since activation of a7-nACh receptors allows sufficient Ca
2+
entry to activate endogenous Ca2+-dependent Cl2 channels in
Xenopus oocytes (for a recent review: [33]), it was important to
determine whether the effect of menthol was exerted on nACh
receptor-mediated currents or on Cl2 currents induced by Ca2+
entry in the cell. Thus, extracellular Ca2+ was replaced with Ba2+
since Ba2+ can pass through a7-nicotinic acetylcholine receptors
but causes a negligible activation of Ca2+-dependent Cl2 channels
[34]. In addition to Ba2+ replacement, a small contribution of
remaining Ca2+-dependent Cl2 channel activity has been shown
to be abolished by the injection of the Ca2+ chelator BAPTA [34].
We tested the effect of menthol in a solution containing 2 mM
Ba2+ in BAPTA-injected oocytes. Menthol (30 mM) produced the
same level of inhibition (6765 in controls versus 6565 in BAPTA-
injected oocytes; n = 7; F (1, 12) = 0.863; ANOVA, P,0.05) on
ACh-induced currents when BAPTA-injected oocytes were
recorded in Ca2+ free solutions containing 2 mM Ba2+ (Fig. 3B).
Menthol has also been reported to alter intracellular Ca2+
homeostasis in various preparations [2]. In the oocyte expression
system, an increased level of intracellular Ca2+ can be detected by
Ca2+-activated Cl2 channels and concomitant alteration in the
holding current [35,36]. However, in control experiments, the
menthol used in this study (30 mM for 15 min) did not alter the
magnitudes of holding-currents in oocytes voltage-clamped at
270 mV (n = 12–14) suggesting that Ca2+-dependent Cl2 chan-
nels are not involved in the effect of menthol in our system.
Recent electrophysiological studies report that menthol inhibits
the functions of Na+ [37,38] and Ca2+ channels [38] in a voltage-
dependent manner. We examined if menthol-inhibition of a7-
nACh receptors was dependent on the membrane potential. As
indicated in Fig. 3C, menthol (30 mM) was able to inhibit ACh
(100 mM)-induced currents at all of the tested potentials and thus
seemingly can act independent of voltage changes. Indeed, an
evaluation of the current-voltage relationship (Fig. 3D) shows that
a7-nACh receptor inhibition by menthol does not change
significantly at varying holding potentials (n = 6–7, inhibition at
220 mV versus 2120 mV; F (1, 11) = 0.058; ANOVA, P.0.05).
It is possible that menthol decreases the binding of ACh to the
nACh receptor by acting as a competitive antagonist at the same
binding site. Concentration-response curves for ACh in the
absence and presence of 30 mM menthol are presented in
Fig. 4A. Menthol did not cause a significant change in the affinity
of ACh for the receptor (EC50 values of 63612 mM versus controls
Figure 1. Effect of menthol on a7-nicotinic acetylcholine receptor-mediated ion currents. (A) Records of currents activated by
acetylcholine (ACh, 100 mM) in control conditions (left), during co-application of 30 mM menthol and acetylcholine after 10 min pretreatment with
30 mM menthol (middle), and 15 min following menthol washout (right). (B) Time-course of the effect of menthol (100 mM) on the peaks of the
acetylcholine-induced currents. Each data point represents the normalized mean 6 S.E.M. of 4 to 5 oocytes. Duration of drug application is indicated
by the horizontal bar in the figure. (C) Comparison of the extent of inhibition caused by 100 mM of (+), (2), and racemic forms of menthol application
for 15 min. Bars represent the means 6 S.E.M. from 6 to 7 cells. (D) Comparison of the effect of 30 mM of racemic menthol application for 15 min on
the currents activated by 100 mM acetylcholine or 10 mM nicotine. Bars represent the means 6 S.E.M. from 5 to 6 cells.
doi:10.1371/journal.pone.0067674.g001
Effects of Menthol on a7-nACh Receptors
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76611 mM; n = 6–8; F (1, 12) = 1.126, ANOVA, P.0.05), but
inhibited the maximal ACh response by about 4764% of controls
(n = 6), suggesting that menthol inhibits the a7-nACh receptor
response in a non-competitive manner.
We determined the effects of 30 mM menthol in radioligand
binding studies using [125I] a-bungarotoxin. Equilibrium curves
for the binding of [125I] a-bungarotoxin, in the presence and
absence (controls) of menthol are presented in Fig. 4B. At a
concentration of 30 mM, menthol did not cause a significant
inhibition of the specific binding of [125I] a-bungarotoxin.
Maximum binding activities (Bmax) of [
125I] a-bungarotoxin were
1.960.3 and 1.760.2 pM/mg (means 6 S.E.M.) for controls and
menthol-treated preparations, respectively (Fig. 4B). The apparent
affinity (KD) of the receptor for [
125I] a-bungarotoxin was
8546236 and 7166213 pM for controls and menthol, respec-
tively. There was no statistically significant difference between
controls and menthol-treated groups with respect to KD (n = 5–6,
F (1, 9) = 1.023; ANOVA, P,0.05) and Bmax KD (n = 5–6, F (1,
9) = 1.066; ANOVA, P,0.05) values.
Because radioligand-binding in oocyte membrane homogenates
is known to disrupt cellular integrity, the subcellular fractions used
in the binding assay are likely to contain both intracellular as well
as plasma membranes. To determine menthol binding and actions
at the cell surface, we also performed radioligand-binding assays in
intact oocytes. In these experiments, menthol (30 mM) did not
cause a significant inhibition of the specific binding of [125I] a-
bungarotoxin (20 nM) in oocytes injected with the a7-nicotinic
acetylcholine receptor cRNA. Specific binding of [125I] a-
bungarotoxin was 15766201 cpm, 14386189 cpm (means 6
S.E.M.) for controls and menthol (30 mM)-treated oocytes,
respectively. In the presence of menthol (30 mM), we did not
detect a significant alteration in the specific binding of [125I] a-
bungarotoxin in intact oocytes (n = 12–14; F (1, 24) = 0.026,
ANOVA; P.0.05). Since a-bungarotoxin competes with ACh at
the same binding site on the a7-nACh receptor, the current data
suggests that menthol does not interact with the ACh binding site;
i.e. acts as a noncompetitive antagonist.
Menthol interacts with a7-nACh receptors in neural cells
and modulates calcium signaling and neurotransmitter
release
a7-nACh receptors are endogenously expressed in PC12 cells
and contribute to cellular growth and function [19]. We have
utilized a culture of NGF differentiated PC12 cells to examine the
effects of menthol on a7-nACh receptor Ca
2+ activity in neural
cells. a7-nACh receptors endogenous to these cells were found to
be distributed in the cell body as well as neurites (Fig. 5A).
Consistent with previous observation, the fluorescent a-bungaro-
toxin (fBgtx) signal was seen at the plasma membrane in soma and
the neurites visualized with f-actin/phalloidin (Fig. 5A). a7-nACh
receptors conduct Ca2+ upon activation leading to important
changes in cellular signaling [14]. We validated the Ca2+
conducting properties of a7-nACh receptors in PC12 cells using
the genetically encoded, high sensitivity, calcium sensor
GCaMP5G [21]. Transfection of GCaMP5G into PC12 cells
allowed us to assay a7-nACh receptor mediated calcium increases
with and without menthol in neural cells. GCaMP5G was
transiently transfected into differentiating PC12 cells 2 days prior
to Ca2+ imaging. As shown in Figs. 5 and 6, pharmacological
activation of the a7-nACh receptor with nicotine or the selective
a7-agonist PNU282987 (PNU) was associated with a significant
increase in intracellular Ca2+ within the soma and primary
neurite. In particular, nicotine was found to promote a 244.3%
(+/250.8%) and 228.9% (+/252.9%) rise in cellular Ca2+ levels
(above basal) within the soma and neurite, respectively. PNU
application was found to only mildly increase Ca2+ levels in the
soma (81.6% (+/238.4%)) while strongly elevating Ca2+ levels in
the neurite (237.4% (+/257.9%)).
We tested the effect of menthol on nicotine and PNU associated
calcium changes. Cells were incubated with 30 mM menthol for
20 min prior to Ca2+ imaging. This pre-application of menthol
was found to dramatically reduce nicotine as well as PNU
mediated Ca2+ thus seemingly maintaining the cellular Ca2+ near
the measured baseline (Figs. 5 and 6). In these experiments, pre-
application of PC12 cells with the a7-nACh receptor blocker a-
bungarotoxin was found to block the effects of nicotine and PNU
on Ca2+ increase, thus confirming the specific role of a7-nACh
receptors in the assay (Figs. 5 and 6).
A binding site for menthol within the a7-nACh receptor
To survey the molecular properties of menthol interaction with
the nACh receptor we utilized structural docking studies using the
nACh muscle receptor; currently, the only complete nACh
receptor available in the Protein Data Bank [23], and menthol.
A protein sequence alignment underscores homology between the
Figure 2. Time and concentration-dependence of menthol
inhibition of a7-nicotinic acetylcholine receptor-mediated ion
currents. (A) Inhibition of the a7-nicotinic acetylcholine receptor
increases with the prolongation of menthol pre-application time. Each
data point represents the mean 6 S.E.M. of 5 to 6 oocytes. (B) Menthol
inhibits a7-nicotinic acetylcholine receptor function in a concentration-
dependent manner. Each data point represents the mean 6 S.E.M. of 7
to 9 oocytes. The curve is the best fit of the data to the logistic equation
described in the methods section.
doi:10.1371/journal.pone.0067674.g002
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muscle nACh receptor and the a7-nACh receptor (Fig. 7A). A
subset of residues, annotated by the red triangle (Fig. 7A), are
found to constitute a possible binding site for menthol on the
nACh receptor using this docking simulation approach.
An analysis of ligand placements with the lowest interaction
energies suggests key residues of menthol binding within the crystal
structure of the muscle nACh receptor. An illustration of a docked
configuration for menthol and the muscle nACh receptor reveal
an h-bond stabilizing menthol association with the nACh receptor
(Fig. 7B panels 3 and 4). This h-bond involves residue THR292 of
the muscle nACh receptor chain A at a distance of 2.21 A˚. Four of
the top ten (lowest-energy) docking configurations for menthol
were found to involve this residue (Fig. 7B panel 3). Another
placement of menthol, noticed on two of the ten lowest-energy
configurations (corresponding to the second lowest interaction
energies of25.98 kcal/mol) involves LEU250 of the muscle nACh
receptor chain A (Fig. 7B panel 4). In this case, menthol is found to
form an h-bond at a distance of 1.97 A˚. While this section of the
sequence alignment is not visible in Fig. 7A, the a7-nACh receptor
was found to also have a LEU residue at the corresponding
position. These results suggest that residues THR292 and LEU250
of the nACh receptor, as based on the crystal structure of the
muscle receptor, can play a key role in menthol binding. Because
of the high sequence homology between the muscle and the a7-
nACh receptor, at these sites, these findings are applicable to
possible menthol interactions with the a7-nACh receptor.
Moreover, it is interesting to point out that since the a7-nACh
receptor is a homopentamer, each of the subunits appears to
maintain a possible menthol binding site.
Discussion
In this study, we provide novel evidence on an interaction
between menthol and the a7- nACh receptor. Our study suggests
that menthol inhibits a7-nACh receptors in a non-competitive
manner thus likely not binding to the ACh site on the receptor.
Studies in cultured neural cells that endogenously express the a7-
nACh receptor evidence on the effect of menthol on a7-nACh
receptor activity in neural cells suggesting that menthol targets
nACh receptors within the brain. At this point of analysis however,
we cannot conclude that menthol directly binds the nACh
receptor. Based on structural modeling studies, a possible menthol
binding appears to exist within the nACh receptor class thus
presenting an important direction of interest in receptor muta-
genesis studies.
In earlier studies, participation of G-protein coupled receptors
such as kappa-opioid receptors [32] and the involvement of G-
proteins in menthol [39] and nicotine [19] induced cellular
responses have been reported. Our results indicate that the effect
of menthol is not sensitive to pertussis toxin thus excluding the
possible role of G-protein signaling in its cellular effect. Menthol
has also been shown to increase intracellular Ca2+ levels and
Figure 3. Inhibition of acetylcholine-induced currents by menthol is independent of the activation of pertussis toxin sensitive
receptors, membrane potential and Ca2+-activated Cl2 channels. (A) Bar presentation of the effects of 30 mM menthol application (15 min)
on the maximal amplitudes of ACh-induced currents in oocytes injected with 50 nl distilled-water, controls (n = 5) or 50 nl of PTX (50 mg/ml, n = 6).
Bars represent the means6 S.E.M. (B) a7-nicotinic acetylcholine receptor expressing oocytes injected with 50 nl distilled water and recorded in 2 mM
Ca2+ containing MBS solution (control) or injected with 50 nl of BAPTA (100 mM) and recorded in 2 mM Ba2+ containing MBS solution (BAPTA). Bars
represent the means 6 S.E.M. of 6 to 8 oocytes. The numbers of oocytes are presented on top of each bar. There was no statistically significant
difference between menthol (30 mM) inhibition in the presence and in the absence of BAPTA injections (P.0.05, n = 5–8, ANOVA). (C) Current-voltage
relationships of acetylcholine-activated currents in the absence and presence of menthol (30 mM). Normalized currents activated by 100 mM
acetylcholine before (control,N) and after 15 min treatment with menthol (#). Each data point presents the normalized means and S.E.M. of five to
six oocytes. (D) Quantitative evaluation of the effect of menthol as percent inhibition at different voltages.
doi:10.1371/journal.pone.0067674.g003
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activate various Ca2+ sensitive kinases [2]. In Xenopus oocytes,
activation of a7-nACh receptors, due to their high Ca
2+
permeability, allows sufficient Ca2+ entry to activate endogenous
Ca2+-dependent Cl2 channels [34]. In oocytes injected with
BAPTA and recorded in a solution containing 2 mM Ba2+,
menthol was found to inhibit a7-nACh receptor-mediated ion
currents, suggesting that Ca2+-dependent Cl2 channels are not
involved in the effect of menthol on the nACh receptor. In
addition, because the reversal potential in solutions containing
Ba2+ was not altered in the presence of menthol, the inhibitory
effects of menthol appear to be not related to changes in the Ca2+
permeability of the a7-nACh receptor-channel. Furthermore, since
Ca2+-activated Cl2 channels are highly sensitive to intracellular
Ca2+ levels (for reviews, [35,36]) alterations in intracellular Ca2+
levels would be reflected by changes in the holding current under
voltage-clamp conditions. However, during our experiments,
application of menthol, even at the high concentrations
(300 mM) used in this study, did not cause alterations in the
holding current, suggesting that menthol does not affect intracel-
lular Ca2+ concentrations.
Open-channel blockade is a widely used model to describe the
block of ligand-gated ion channels [40]. However, this model
does not appear to account for our results based on two key
observations: 1. Unlike open channel blockers, in which the
agonist is required to allow the channel blocker to enter the
channel after a conformational change, pre-application of
menthol was found to augment its own inhibition of the a7-
nACh receptor (Fig. 2), suggesting that menthol interacts with
the closed state of the receptor; 2. inhibition by menthol appears
to be not voltage sensitive, suggesting that the menthol-binding
to the channel is not affected by the transmembrane electric
field.
Menthol, in the concentration ranges used in this study, has
been shown to act directly on the several ligand-gated ion channels
including GABA-A ([38]; EC50 = 1.1 mM), glycine ([41]; 100–
300 mM), and the a4b2 nACh receptor ([12]; IC50 = 111 mM). In
addition, menthol appears to modulate a number of voltage-gated
ion channels ([38]; IC50 = 297 mM for Na
+ channels and IC50 of
125 mM Ca2+ channels in dorsal horn neurons). We find that
menthol concentrations capable of producing an effect on the a7-
nACh receptor in Xenopus oocytes are lower then the concentra-
tions found to activate TRPM8 channels [42]. Menthol non-
selectively also activates TRPV3 (EC50 20 mM), inhibits mouse
TRPA1 (IC50 = 68 mM) [43]. In our study, the concentration of
menthol effective on human a7-nACh receptor ranged from 3 mM
to 1 mM (IC50 = 32.6 mM). Similar concentrations of menthol
were found effective on endogenous a7-nACh receptor in rat
neuroendocrine cells. These concentrations approximate those
used in human psychophysical studies and are considerably lower
than those used in over-the-counter products (<500 mM) [44,45].
Menthol taken orally is effectively absorbed in gastro-intestinal
mucosa and can easily reach the range of menthol concentrations
used in this study suggesting that can act a7-nACh receptors
within humans.
Figure 4. Concentration-response curves for acetylcholine-induced currents and binding of [125I] a-bungarotoxin in control and in
the presence of menthol. (A) Effect of menthol on the acetylcholine concentration-response relationship. Oocytes were voltage-clamped at
270 mV and currents were activated by applying acetylcholine (1 mM to 3 mM). Oocytes were exposed to 100 mM menthol for 15 min and
acetylcholine was reapplied. Paired concentration-response curves were constructed and responses normalized to maximal response under control
conditions. EC50 and slope values were determined by fitting the curves from 6 to 8 oocytes to the standard logistic equation as described in the
methods section. Data points obtained before (control) and after 15 min treatment with menthol (100 mM) were indicated by filled circles, open
circles, and open triangles, respectively. Each data point presents the normalized means and S.E.M. of five to six experiments. (B) The effects of
menthol on the specific binding of [125I] a-bungarotoxin to oocyte membrane preparations. In the presence and absence of menthol, specific binding
as a function of the concentration of [125I] a-bungarotoxin is presented. Data points for controls and menthol (100 mM) are indicated by filled circles,
and open circles, respectively. Data points are the means of three independent experiments carried out in triplicate.
doi:10.1371/journal.pone.0067674.g004
Effects of Menthol on a7-nACh Receptors
PLOS ONE | www.plosone.org 7 July 2013 | Volume 8 | Issue 7 | e67674
Based on electrophysiological studies, we find that only the
efficacy, and not the potency, of ACh was inhibited by menthol.
We propose that that menthol does not compete with ACh to the
same binding site on the a7-nACh receptor. In agreement with
this, our radioligand binding studies indicate that the specific
binding characteristics of [125I] a-bungarotoxin, which shares the
same binding site as ACh, are also not affected by menthol. Using
computational modeling we find that menthol binds the nACh
receptor at LEU and THR at sequence positions 250 and 292
respectively (Fig. 7). While modeling is based on the structure of
the muscle nACh receptor, these menthol binding sites appear
conserved in the human a7-nACh receptor subunit. Collectively,
these findings indicate that menthol can act as an allosteric
inhibitor of the a7-nACh receptor a property allowing it to
modulate the receptor at various concentrations of ACh or
nicotine. Interestingly, in the concentration range used in this
study, menthol has been reported to inhibit the activity of
acetylcholine esterase, [46,47]. The inhibition of nicotine-induced
[3H]NE release by menthol indicates that the actions of menthol
observed in the expression systems and single cells also occur in
neurons and may therefore contribute to neuronal circuitry and
function.
Interaction between menthol and nACh receptors has been
studied in several earlier investigations [9,11,12]. Nicotine, a
major irritant contained in tobacco smoke [48], elicits burning or
stinging pain sensation on oral or nasal mucosa [9]. Nicotine
induced sensations are thought to involve activation of nACh
receptors, including those composed of the a7 subunit, expressed
Figure 5. Menthol attenuates nicotine-induced calcium signaling in neural cells. (A) A representative PC12 cell showing the expression of
a7-nACh receptors in the soma and primary neurite. Green fluorescence: fBgtx labeling; red fluorescence: anti-rhodamine phalloidin immunostaining
was used to determine ROI for calcium imaging. (B) Live cell imaging of cells expressing the genetically encoded calcium sensor GCaMP5G. ROI
within soma and neurite shown via the orange and red dotted lines, respectively. Rows top to bottom: cells pre-treated with Control (0.3% ethanol);
Menthol (30mM); a-bungarotoxin (Bgtx) (50nM). Cellular images captured at 6/8/10/12 seconds (s). Nicotine (50mM) was applied at 8-10s. (C) Average
fluorescence signal data for soma and neurite ROI imaged for 20 seconds. n = 40 cells, **P.0.01’’.
doi:10.1371/journal.pone.0067674.g005
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in the sensory fibers innervating these tissues [49] and in bronchial
and tracheal epithelia of the pulmonary tissue [50,51]. Nicotine
induced irritation and sensory perception is reduced by menthol
[9]. Recently, menthol has been shown to act as counter-irritant
against inhaled cigarette smoke [11] suggesting that nicotine-
induced responses are reduced by menthol. In addition to sensory
responses, one of the major physiological effects of nicotine is a
decrease in body temperature due to cutaneous vasodilation, an
action originating in brain probably mediated by hypothalamic
nicotinic receptors [52]. Both chronic and acute menthol
administrations diminish the effect of nicotine on body temper-
ature [10].
It is interesting to consider that menthol, a common
cigarette additive, has been associated with a greater tobacco
dependence potential and lower success in cessation attempts
[3,7,4]. A reduction in a7 nACh receptor function has been
proposed to constitute a biological mechanism for increased
motivation for cigarette smoking [53,54]. Several earlier
genetic studies demonstrate that reductions in a7-nACh
receptor function result in significant elevations in motivation
to self-administer nicotine [55,56]. Similarly, antagonism of a7
nACh receptors in the anterior cingulate cortex was found to
be sufficient to increase nicotine self-administration [54].
Based on these findings, it is likely that higher levels of
nicotine addiction observed in mentholated cigarette users
[57] involve antagonistic actions of menthol on a7 nACh
receptors.
Menthol is known to act stereo-selectively in some, but not all, in
vivo and in vitro assay systems (for reviews, 1, 2]. In an earlier study,
Hall et al [41] showed that the effect of menthol on GABAA
currents were stereo-selective with (+)-menthol being more potent
than (2)-menthol, while menthol modulation of glycine-receptors
did not display stereo-specificity. In our study, we could not detect
a stereo-selectivity of menthol actions on a7-nACh receptor
(Fig. 1). Cyclohexane (100 mM), aromatic skeleton of menthol,
displayed undetectable efficacy at inhibiting a7-nACh receptor.
The substitution pattern on the cyclohexane skeleton and an
aromatic hydroxyl group caused a significant increase in the
potency of menthol and propofol in inhibiting a7-nACh receptor.
The results observed for the parent compound cyclohexane and
derivatives thereof may be useful in further understanding the
molecular mechanisms involved in pharmacological effects of
menthol as well as propofol. Other terpenes with close structural
similarities to menthol, such as camphor [58] and borneol [59]
have also been shown to inhibit the function of nACh receptors in
a noncompetitive manner in chromaffin cells. Clearly, further
structure-activity relationship studies are required in future
investigations. These data add to a growing body of evidence [2]
suggesting that in addition to TRPM8 receptors, a7-nACh
receptors are pharmacologically targeted by menthol in cells.
Figure 6. Menthol attenuates a7 nACh receptor calcium signaling. (A) Live cell imaging of cells expressing GCaMP5G. ROI within soma and
neurite shown via the organge and red dotted line, respectively. ROI selection is based on co-detection of fBgtx and GCaMP5G as indicated in Fig. 5.
Rows top to bottom: cells pre-treated with Control (0.3% ethanol); Menthol (30 mM); a-bungarotoxin (Bgtx) (50 nM). Image frames captured at 6/8/
10/12 seconds (s). PNU (10 mM) was applied at 8–10 s. (B) Average fluorescence signal data for soma and neurite ROI imaged for 20 seconds. n = 40
cells, **P.0.01’’.
doi:10.1371/journal.pone.0067674.g006
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Figure 7. A multiple sequence alignment and conservation scores obtained with MUSCLE Vr. 3.8.31 [30] between the human
GABAAR-a1 subunit (UniProt AC: P14867), human a7-nACHR (UniProt AC:P36544 and the muscle nACh receptor subunit chain A
([24]; PDB ID: 2BG9) in (A). The fragment highlights, through the boxed and shaded region, key residue positions from the M3 segment of
GABAAR-a1 evaluated by Williams and Akabas [29] for propofol binding. The docking simulation indicates binding of the menthol ligand on muscle
nACh receptor residue THR292. This position is indicated by the red triangle and corresponds to the most frequent docking site. High sequence
conservation about the binding site with muscle nACh receptor could indicate similar binding site characteristics for a7-nACh receptor. (B)
Representative docked configuration for menthol (ZINC ID: 01482164) on the crystal structure of muscle nACh receptor ([24]; PDB ID: 2BG9). 1) Top-
down view of nACh receptor with chain A colored in blue, B in red, C in gray, D in orange, and E in yellow. The binding site for the ligand is circled. As
the a7-nACh receptor is a homopentamer, this conserved binding site could also be found on all five receptor subunits of the functional receptor. 2)
Side-view of the circled binding site. 3) Lowest-energy (26.15 kcal/mol) configuration, on four of the ten simulations resulting in lowest interaction
energies, is shown for the L-menthol ligand. The h-bond that stabilizes the ligand onto the crystal structure is formed at residue THR292 of the muscle
nACh receptor chain A (blue) at a distance of 2.21 A˚. 4) The second most-frequent configuration for the ligand, corresponding to interaction energy
of 25.98 kcal/mol, obtained on two of the top ten simulations. An h-bond with residue LEU250 of chain A (blue) at a distance of 1.97 A˚ stabilizes this
docked configuration.
doi:10.1371/journal.pone.0067674.g007
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